WHO ICTRP trial
The mesenchymal stem cell-derived extracellular vesicles for postmenopausal…
IRCT20131009014957N15 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20131009014957N15 |
|---|---|
| Public title | The mesenchymal stem cell-derived extracellular vesicles for postmenopausal osteoporosis |
| Scientific title | The mesenchymal stem cell-derived extracellular vesicles for primary postmenopausal osteoporosis: A safety, feasibility, and efficacy trial. |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 1-2 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Postmenopausal osteoporosis. Osteoporosis without pathological fracture |
| Interventions | Intervention 1: Intervention group 1: Receiving intravenous extracellular vesicles derived from stem cells Mesenchymal (MSCs-EV) together with alendronate sodium tablets 70 mg once a week until the end of one year. This group will receive… |
| Registration date | Sep 26, 2023 |
| Target size | 30 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: